Product Description
Sorafenat 200mg Tablet belongs to the class of medicines known as tyrosine kinase inhibitors used in the treatment of liver cancer, kidney cancer, and thyroid cancer.Sorafenat 200mg Tablet should be taken on an empty stomach, but try to have it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.Fatigue, nausea, loss of appetite, hair loss and diarrhea are some common side effects of this medicine. It might cause high blood pressure, so the doctor may ask you for a regular check-up of blood pressure. You must inform your doctor if you notice severe skin reaction such as skin rash, or any pain, swelling, and redness of your hands and feet.Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or high blood pressure. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.Powerful Targeted TherapySorafenat Sorafenib Tablets function as a potent targeted kinase inhibitor, disrupting cancer cell growth and progression. This oral medication is designed to combat advanced stages of certain cancers, offering a convenient and effective treatment option under medical supervision.
Safe and Convenient PackagingEach bottle of Sorafenat contains 120 tablets sealed in an HDPE container equipped with a child-resistant cap. This ensures safety, maintains drug integrity, and provides convenience for both patients and healthcare professionals during treatment courses.
Versatile Oncological ApplicationSorafenat is indicated for patients with advanced renal cell carcinoma, unresectable hepatocellular carcinoma, and differentiated thyroid carcinoma. Its oral administration enables greater flexibility in daily healthcare routines while ensuring targeted delivery directly to the patient's system.
FAQ's of Sorafenat Sorafenib Tablets:
Q: How should Sorafenat Sorafenib Tablets be administered?
A: Sorafenat tablets are intended for oral use and must be taken exactly as prescribed by a qualified physician, usually with or without food. The tablets should be swallowed whole with water rather than chewed or crushed.
Q: What conditions does Sorafenat Sorafenib treat?
A: Sorafenat is used to treat advanced renal cell carcinoma, unresectable hepatocellular carcinoma, and differentiated thyroid carcinoma. It works as a targeted therapeutic agent to inhibit the growth and spread of cancer cells.
Q: When is it necessary to use Sorafenat under medical supervision?
A: Sorafenat Sorafenib is a prescription-only medicine and must always be used under the guidance and close supervision of a qualified healthcare provider to monitor response, manage any side effects, and ensure safe usage.
Q: Where should Sorafenat Sorafenib Tablets be stored for safety and effectiveness?
A: The tablets should be stored in their original HDPE bottle below 30C, away from moisture and direct sunlight, to maintain their efficacy throughout the 24-month shelf life.
Q: What is the main benefit of Sorafenat as an anti-cancer therapy?
A: As a targeted kinase inhibitor, Sorafenat offers a focused mechanism of action that interferes with cancer cell development, potentially improving outcomes and minimizing damage to healthy cells in comparison to traditional chemotherapy.
Q: How can patients obtain Sorafenat Sorafenib Tablets?
A: Patients can acquire Sorafenat only through a valid prescription, typically from licensed distributors, exporters, or suppliers in India as managed by Natco Pharma Limited.